Bariatric Surgery Improves Lipid (Cholesterol) Profiles

Weight loss is the most visible benefit of bariatric surgery, but these procedures also trigger significant metabolic changes that improve lipid profiles, including dyslipidemia and hyperlipidemia. Dyslipidemia refers to any abnormal lipid levels, such as high LDL cholesterol, low HDL cholesterol, or elevated triglycerides. Hyperlipidemia specifically refers to elevated cholesterol or triglycerides. Both conditions are major risk factors for cardiovascular disease and are commonly associated with obesity.

LDL (low-density lipoprotein) carries cholesterol from the liver to the rest of the body. When there’s too much LDL in the bloodstream, it can deposit cholesterol in the arterial walls, leading to plaque buildup (atherosclerosis). This increases the risk of heart attack and stroke. Hence, we call LDL “bad” cholesterol, because it’s bad for us at high levels. HDL (high-density lipoprotein) does the opposite. It helps remove excess cholesterol from the bloodstream and artery walls and transports it back to the liver for disposal. Higher HDL levels are generally associated with lower cardiovascular risk. So, we refer to HDL as “good” cholesterol.

The best scenario is low LDL, low triglycerides, and adequately high HDL – this shifts the lipid profile in a cardioprotective direction. Many bariatric patients experience substantial improvements in total cholesterol, LDL, HDL, and triglycerides, sometimes achieving complete remission of lipid abnormalities.

How the Reset Happens

Research shows that bariatric procedures help correct lipid metabolism through multiple, complementary mechanisms.

1. Adipose Tissue Changes

Excess body fat is a major storage site for cholesterol, with some patients storing over 50% of their body cholesterol in adipose tissue (fat). Bariatric surgery reduces body fat, thereby lowering circulating cholesterol levels.¹ Weight loss surgery also changes the distribution and function of adipose tissue that is retained, further reducing lipid abnormalities.

2. Hormone and Metabolic Alterations

Bariatric surgery alters gut hormones, insulin sensitivity, and liver fat metabolism, all of which are connected to lipid profile improvement:

• Altered bile acid signaling and gut microbiome composition enhance lipid metabolism.²
• Improved insulin action reduces LDL production and circulating triglycerides.³
• Reductions in chronic inflammation support healthier liver function and cholesterol processing.⁴

Insulin sensitivity begins to sharpen within weeks of weight loss surgery, even before significant weight loss. It happens in conjunction with changes in gut hormones, bile acids, and the gut microbiome, restructuring how the liver processes sugar and fats. Metabolic changes emerge early on, indicating a weight-independent mechanism at work. As weight loss progresses, weight-dependent reductions in inflammation and liver fat further enhance insulin action and lipid metabolism. The body becomes better at handling sugar and fat both quickly after surgery and even more so as weight continues to come off.

Procedure-Specific Lipid Effects

Not all bariatric procedures have the same impact on lipid profiles, and the type of surgery chosen is carefully matched to each patient’s medical history and metabolic needs. Gastric bypass consistently produces significant reductions in total cholesterol, LDL cholesterol, and triglycerides, along with increases in HDL cholesterol.⁵ Sleeve gastrectomy also improves cholesterol and triglyceride levels, though the effects are generally more modest than bypass procedures.⁵ A detailed evaluation of lipid abnormalities, cardiovascular risk, insulin resistance, and long-term nutritional considerations are essential factors to consider when deciding on the appropriate surgery.

Long-Term Outcomes

Weight loss surgery is a metabolic intervention that can reduce cardiovascular risk and, in many cases, allow patients to reduce or stop lipid-lowering medications.

Long-term studies confirm that improvements in lipid profiles are sustained beyond one year, and observational studies suggest that bariatric surgery reduces cardiovascular disease risk and overall mortality in patients with obesity and dyslipidemia.⁶

Time after time, we see what a powerful tool bariatric surgery is for patients struggling with obesity. These procedures produce durable systemic improvements in health and longevity.

Dr. Higa is the Medical Director of Bariatric Surgery for the Carondelet Health Network and the Minimally Invasive Bariatric Surgery Medical Director for St. Mary’s and St. Joseph’s Hospitals in Tucson, AZ. With 20 years of experience, he is certified by the American Board of Surgery and holds professional memberships with the American College of Surgeons, American Society of Metabolic & Bariatric Surgery, and the Society of American Gastrointestinal & Endoscopic Surgeons.

1. National Lipid Association. (2016, February 16). New Joint Scientific Statement Issued on Use of Bariatric Surgery to Improve Cholesterol Levels and Reduce Risk of Heart Disease. Lipid.org. https://www.lipid.org/nla/new-joint-scientific-statement-issued-use-bariatric-surgery-improve-cholesterol-levels-and.
2. Bays, H., Kothari, S. N., Azagury, D. E., Morton, J. M., Nguyen, N. T., Jones, P. H., Jacobson, T. A., Cohen, D. E., Orringer, C., Westman, E. C., Horn, D. B., Scinta, W., & Primack, C. (2016). Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 12(3), 468–495. https://doi.org/10.1016/j.soard.2016.01.007.
3. Heffron, S., Parikh, A., Volodarskiy, A., Ren-Fielding, C., Schwartzbard, A., Nicholson, J., & Bangalore, S. (2016). Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis. The American Journal of Medicine, 129(9), 952–959. https://doi.org/10.1016/j.amjmed.2016.02.004.
4. Illán-Gómez, F., Gonzálvez-Ortega, M., Orea-Soler, I., Alcaraz-Tafalla, M. S., Aragón-Alonso, A., Pascual-Díaz, M., Pérez-Paredes, M., & Lozano-Almela, M. L. (2012). Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obesity surgery, 22(6), 950–955. https://doi.org/10.1007/s11695-012-0643-y.
5. Heffron, S., Parikh, A., Volodarskiy, A., Ren-Fielding, C., Schwartzbard, A., Nicholson, J., & Bangalore, S. (2016). Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis. The American Journal of Medicine, 129(9), 952–959. https://doi.org/10.1016/j.amjmed.2016.02.004.
6. Climent, E., Benaiges, D., Goday, A., Villatoro, M., Julià, H., Ramón, J. M., Flores, J. A., & Pedro-Botet, J. (2020). Morbid obesity and dyslipidaemia: The impact of bariatric surgery. Obesidad mórbida y dislipemia: impacto de la cirugía bariátrica. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 32(2), 79–86. https://doi.org/10.1016/j.arteri.2019.11.001.